The LAMP Story and What It Means for ANCA Positive Vasculitis in Nephrology

QR Code

The LAMP Story and What It Means for ANCA Positive Vasculitis in Nephrology

None

Saved in:

Bibliographic Details
Main Author:	Rothe, Hansjörg
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/21635
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment of ANCA – Associated Vasculitis
by: Katsiari, Christina G., et al.
Published: (2011)

The Role of Proteinase 3 and Neutrophils in ANCA-Associated Systemic Vasculitis
by: Abdgawad, Mohamed
Published: (2011)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

ANCA Diagnostics in Clinical Practice: New Developments
by: Damoiseaux, Jan, et al.
Published: (2011)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Histopathology of Cutaneous Vasculitis
by: Chen, Ko-Ron
Published: (2011)

Endothelial Cells and Vasculitis
by: Djordjević, Vidosava B., et al.
Published: (2011)

Drug-Induced Vasculitis
by: Radić, Mislav
Published: (2011)

Treatment of Different Types of Vasculitis
by: Imanishi, Hisayoshi, et al.
Published: (2011)

Quality of Life Issues in Vasculitis
by: Carpenter, Delesha, et al.
Published: (2011)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study
by: M. A. Litvinova, et al.
Published: (2025-04-01)

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT
by: L. M. Kudelya, et al.
Published: (2020-03-01)

FDG-PET in Large Vessel Vasculitis
by: Ng, Quinn K.T., et al.
Published: (2011)

Biologic Agents for the Treatment of Systemic Vasculitis
by: Sfriso, P., et al.
Published: (2011)

Drug Induced Small Vessel Vasculitis
by: Barriga, Jorge Daza, et al.
Published: (2011)

Audiovestibular Manifestations in Systemic Vasculitis: An Update
by: Amor-Dorado, Juan Carlos, et al.
Published: (2011)

Aortitis and aortic aneurysm in systemic vasculitis
by: García-Martínez, Ana, et al.
Published: (2011)

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
by: Mitchell Salke, et al.
Published: (2025-06-01)

Pulmonary and Renal Predictors of Mortality in ANCA-Associated Vasculitis: A Regional Experience from Türkiye
by: Dilara Bulut Gökten, et al.
Published: (2025-06-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

The Role of Biological Therapies in the Management of Systemic Vasculitis
by: Vela, Paloma, et al.
Published: (2011)

Vasculitis: Endothelial Dysfunction During Rickettsial Infection
by: Bechah, Yassina, et al.
Published: (2011)

Responsible Genetic Factors for Vasculitis in Kawasaki Disease
by: Onouchi, Yoshihiro, et al.
Published: (2011)

Vasculitis as a Cause of First-Ever Stroke
by: Wiszniewska, Malgorzata, et al.
Published: (2011)

Disparities in ethnicity and metabolic disease burden in referrals to nephrology
by: Yan Ting Chua, et al.
Published: (2025-06-01)

Psychosocial Factors in Fibromyalgia: A Qualitative Study on Life Stories and Meanings of Living with Fibromyalgia
by: Oliveira, Paula J., et al.
Published: (2012)

Immunopathogenesis Based Adamantiades- Behcet Disease Vasculitis Treatment
by: Boura, Panagiota, et al.
Published: (2011)

Bypass for the Treatment of Vasculitis Affecting the Central Nervous System
by: Rodríguez-Hernández, Ana, et al.
Published: (2011)

Late-onset neutropenia induced by anti-B cell therapy with rituximab in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2022-06-01)